结构DPPIV:一种基于原子结构的新型深度学习模型,用于预测二二酶-IV抑制
Ding Wang1, Junru Jin1, Zhongshen Li1
1School of Software, Shandong University, Jinan 250101, China.
Bioinformatics (Oxford, England)
|February 2, 2024
概括
研究人员开发了StructuralDPPIV,这是一个深度学习工具,用于识别二二酶IV抑制 (DPP-IV-IPs). 这通过克服当前酸开采方法的局限性,推动了抗糖尿病药物发现.
科学领域:
- 生物化学 生物化学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 糖尿病是一种全球性的健康危机,导致严重的并发症,如失明和心血管疾病.
- 双类酶IV抑制 (DPP-IV-IPs) 是一种有前途的抗糖尿病治疗药物.
- 目前的矿工具阻碍了对新型DPP-IV-IP的有效发现.
研究的目的:
- 引入结构DPPIV,这是一种用于识别DPP-IV-IP的新型深度学习模型.
- 为了增强下一代抗糖尿病药物的发现管道.
主要方法:
- 开发了结构DPPIV,这是一个集成分子图形特征和氨基酸序列信息的深度学习模型.
- 在独立测试和湿实验数据集上验证了模型的性能.
- 雇员类激活映射 (CAM) 和扰动实验用于模型可解释性.
主要成果:
- 与现有的最先进的方法相比,结构DPPIV表现出更高的性能.
- 该模型在识别DPP-IV-IP时实现了高精度.
- 解释性分析为模型的预测推理提供了洞察力.
结论:
- 结构DPPIV是DPP-IV-IP识别的有效和可解释的工具.
- 该模型加速了潜在的抗糖尿病药物的发现.
- 该代码的开源可用性有助于进一步的研究和开发.
更多相关视频
13:34Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
Published on: December 30, 2016
11.6K
08:232 in 1: One-step Affinity Purification for the Parallel Analysis of Protein-Protein and Protein-Metabolite Complexes
Published on: August 6, 2018
11.4K
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
187
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
187
Intrinsically Disordered Proteins
17.8K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
17.8K
Glucagon-like Receptor Agonists
323
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
323
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
